The subcutaneous dose had comparable efficacy to intravenous dosing while enhancing patient convenience in non–small cell lung cancer, explains Nicolas Girard, MD, PhD.
Nicolas Girard, MD, PhD
Advertisement
Nicolas Girard, MD, PhD, is head of the medical oncology department at Institut Curie in France.
Articles by Nicolas Girard, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
3
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
4
How Can Trauma Affect the Menopausal Transition?
5
